The Relationship Between Personality Traits and Perioperative Anesthetic Drug Consumption

March 26, 2025 updated by: SEZGİN BİLGİN, Ondokuz Mayıs University
In this study, we aimed to examine the association between personality traits and amount of anesthetic drug consumption,of the patients who will receive sedoanalgesia for the oocyte retrieval procedure. As well as determining the anxiety scores in the preoperative period, the time to reach the desired sedation level, hemodynamic parameters in the perioperative period, peripheral oxygen saturation, EtCO2 value, postoperative pain, postanesthetic recovery, analgesic drug need, unconscious movement, and patient satisfaction.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Different personality traits, anxiety disorders, depression, and somatoform disorders are frequently encountered in women with infertility problems. Although there are many studies evaluating the relationship of anxiety with variables such as hemodynamic parameters, need for anesthetic medication, recovery times, postoperative pain and analgesic requirements, the relationship between personality traits and these variables has not been investigated.

In our study, considering that the anesthesia needs of these patients with a stressful negative factor such as infertility may be at different levels, preoperative evaluation of the patients with a personality questionnaire will provide better perioperative management, a better quality recovery and possibly a higher quality oocyte aspiration. In this study, it was aimed to investigate the amount of anesthetic agent consumption, recovery times, postoperative pain scores, analgesic requirements, involuntary movement, time to reach sufficient sedation depth, and patient satisfaction of patients thought to have sedation.

All patients will fill out Personality Belief Scale-Short Form (PBQ-S1) and Beck Anxiety Scale one day before the procedure and they will be registered.

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Atakum
      • Samsun, Atakum, Turkey, 55000
        • Ondokuz Mayis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Female patients between 18-50 ages who will undergo oocyte pick up procedure with sedation

Description

Inclusion Criteria:

  • 18- 50 year-old elective patients who signed the informed consent form from ASA I-II patients scheduled for oocyte retrieval.
  • Patients with sufficient education and mental capacity to complete in assessment scales and questionnaires.
  • Patients without neurological disorders, psychological illnesses, or drug or alcohol abuse
  • Patients without stimulant drug and alcohol consumption
  • Absence of significant cardiovascular, respiratory, kidney or liver disease.

Exclusion Criteria:

  • Psychiatric or neurological disorder
  • Psychiatric drug use or alcohol consumption
  • Pregnancy
  • Presence of severe cardiac, hepatic or cerebrovascular disease
  • History of allergy to local anesthetics or systemic opioids
  • History of chronic pain
  • Patients who are unable to evaluate scales and questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group PT-PADC
patients who will receive sedoanalgesia for the oocyte retrieval procedure.
All patients will fill out Personality Belief Scale-Short Form (PBQ-S1) and Beck Anxiety Scale one day before the procedure and they will be registered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Propofol consumption
Time Frame: from the beginning to the end of the transvaginal oocyte retrieval procedure)
mg, from the beginning to the end of the transvaginal oocyte retrieval procedure
from the beginning to the end of the transvaginal oocyte retrieval procedure)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time until the Ramsey Sedation Score of 4 is reached
Time Frame: -The period of time starting with the propofol injection until the Ramsey Sedation Score of 4
The period elapsed after the patient is transported to the operating table and the sedation protocol begins.
-The period of time starting with the propofol injection until the Ramsey Sedation Score of 4
Amount of propofol (mg) used until the required sedation depth is reached
Time Frame: The period of time starting with the propofol injection until the Ramsey Sedation Score of 4
The amount of iv propofol administered until the Ramsey Sedation Score of 4 is obtained
The period of time starting with the propofol injection until the Ramsey Sedation Score of 4
Systolic, diastolic and, mean Blood pressure (mm/Hg)
Time Frame: every 5 minutes during the procedure
It will be monitored and documented every 5 minutes during the procedure.
every 5 minutes during the procedure
Heart rate (beats/min)
Time Frame: every 5 minutes during the procedure.
It will be monitored and documented every 5 minutes during the procedure.
every 5 minutes during the procedure.
Peripheral oxygen saturation (%)
Time Frame: every 5 minutes during the procedure
(%): It will be monitored and documented every 5 minutes during the procedure.
every 5 minutes during the procedure
Number of Involuntary movement during the procedure
Time Frame: during the procedure.
The presence of involuntary movement will be documented during the procedure.
during the procedure.
Postoperative pain (visual analog scale)
Time Frame: After the procedure,every 30 minutes up to 1 hour
Pain status will be evaluated based on visual analog scale (VAS) at rest and after movement.every 30-minute intervals for one hour in the recovery room. Each VAS is scores 0-10 (0=no pain, 10=unbearable pain)
After the procedure,every 30 minutes up to 1 hour
Analgesic consumption
Time Frame: postoperatively up to 2 hours
The analgesic agents administered to the patients throughout the postoperative period will be documented.
postoperatively up to 2 hours
Postoperative recovery time
Time Frame: postoperatively up to 2 hours
The time until the Modified Aldrete Score reaches 9 points will be determined.
postoperatively up to 2 hours
The incidences of post-operative nausea and vomiting (PONV)
Time Frame: the time from the end of the procedure until discharge
the presence of nausea and vomiting will be recorded for 24 hours after procedure
the time from the end of the procedure until discharge
Undesirable events and interventions
Time Frame: time between start of procedure and discharge
Bradycardia, hypotension, airway obstruction, hypoxia will be documented throughout the perioperative phase with the intervention.
time between start of procedure and discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Actual)

March 30, 2024

Study Completion (Actual)

July 30, 2024

Study Registration Dates

First Submitted

July 10, 2023

First Submitted That Met QC Criteria

October 17, 2023

First Posted (Actual)

October 23, 2023

Study Record Updates

Last Update Posted (Actual)

April 1, 2025

Last Update Submitted That Met QC Criteria

March 26, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PT-PADC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe